Form Type: 4

SEC EDGAR Link
Accession Number:0001209191-20-042653
Date:2020-07-14
Issuer: VIR BIOTECHNOLOGY, INC. (VIR)
Original Submission Date:

Reporting Person:

VIRGIN HERBERT
C/O VIR BIOTECHNOLOGY, INC.
499 ILLINOIS STREET, SUITE 500 SAN FRANCISCO, CA 94158

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2020-07-14 M 7,900 a $1.53 7,900 direct
COMMON STOCK 2020-07-14 S 7,900 d $48.85 0 direct
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
STOCK OPTION (RIGHT TO BUY) 1.53 2020-07-14 deemed execution date M 7,900 (d) 2028-01-26 common stock 7,900 $1.53 516,055 direct
Footnotes
IDfootnote
f1 the sales reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on april 14, 2020.
f2 the price reported in column 4 is a weighted average price. these shares were sold in multiple transactions at prices ranging from $48.7897 to $48.8922, inclusive. the reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the securities and exchange commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
f3 1/4 of the shares subject to the stock option vested and became exercisable on january 8, 2019, and the remaining shares vest in 36 equal monthly installments thereafter.
WhaleWisdom Logo

Elevate your investments